Literature DB >> 2479288

Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase.

C E Furlong1, R J Richter, S L Seidel, L G Costa, A G Motulsky.   

Abstract

Human serum plasma paraoxonase/arylesterase exhibits a genetic polymorphism for the hydrolysis of paraoxon. One allelic form of the enzyme hydrolyzes paraoxon slowly with a low turnover number and the other(s) hydrolyzes paraoxon rapidly with a high turnover number. Chlorpyrifos-oxon, the active metabolite of the insecticide chlorpyrifos (Dursban), is also hydrolyzed by plasma arylesterase/paraoxonase. A specific assay for measuring hydrolysis of this compound is described. This assay is not subject to interference by the esterase activity of serum albumin. The Km for chlorpyrifos-oxon hydrolysis was 75 microM. Hydrolysis was inhibited by phenyl acetate, EDTA, and organic solvents. Enzyme activity required calcium ions and was stimulated by sodium chloride. Hydrolysis was optimized by using methanol instead of acetone to dissolve substrate. Unlike the multimodal distribution of paraoxonase, the distribution of chlorpyrifos-oxonase activity failed to show clear multimodality. An improvement in the assay for hydrolysis of paraoxon by plasma arylesterase/paraoxonase was achieved by elimination of organic solvents. Plotting chlorpyrifos-oxonase activity vs paraoxonase activity for a human population using the new assay conditions provided an excellent resolution of low activity homozygotes from heterozygotes for this allele. A greater than 40-fold difference in rates of chlorpyrifosoxon hydrolysis observed between rat (low activity) and rabbit sera (high activity) correlated well with the reported large differences in LD50 values for chlorpyrifos in these two animals, consistent with an important role of serum paraoxonase in detoxification of organophosphorus pesticides in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479288     DOI: 10.1016/0003-2697(89)90424-7

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  43 in total

1.  Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer disease.

Authors:  Porat M Erlich; Kathryn L Lunetta; L Adrienne Cupples; Carmela R Abraham; Robert C Green; Clinton T Baldwin; Lindsay A Farrer
Journal:  Neurobiol Aging       Date:  2010-10-27       Impact factor: 4.673

Review 2.  Human PON1, a biomarker of risk of disease and exposure.

Authors:  C E Furlong; S M Suzuki; R C Stevens; J Marsillach; R J Richter; G P Jarvik; H Checkoway; A Samii; L G Costa; A Griffith; J W Roberts; D Yearout; C P Zabetian
Journal:  Chem Biol Interact       Date:  2010-03-23       Impact factor: 5.192

3.  Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds.

Authors:  Karen L Jansen; Toby B Cole; Sarah S Park; Clement E Furlong; Lucio G Costa
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-09       Impact factor: 4.219

4.  Enzymatic detoxification of organophosphorus pesticides and related toxicants.

Authors:  Karla Alejo-González; Erik Hanson-Viana; Rafael Vazquez-Duhalt
Journal:  J Pestic Sci       Date:  2018-02-28       Impact factor: 1.519

5.  PON1 status does not influence cholinesterase activity in Egyptian agricultural workers exposed to chlorpyrifos.

Authors:  Corie A Ellison; Alice L Crane; Matthew R Bonner; James B Knaak; Richard W Browne; Pamela J Lein; James R Olson
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-10       Impact factor: 4.219

6.  Paraoxonases-1, -2 and -3: What are their functions?

Authors:  Clement E Furlong; Judit Marsillach; Gail P Jarvik; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-05-26       Impact factor: 5.192

7.  Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure.

Authors:  Aydin Ece; Yildiz Atamer; Fuat Gürkan; Mehmet Davutoğlu; Meki Bilici; Murat Tutanç; Ali Güneş
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

8.  Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.

Authors:  Natasa Stanisavljevic; L Stojanovich; D Marisavljevic; A Djokovic; V Dopsaj; J Kotur-Stevuljevic; J Martinovic; L Memon; S Radovanovic; B Todic; D Lisulov
Journal:  Clin Rheumatol       Date:  2016-08-25       Impact factor: 2.980

9.  Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotype.

Authors:  R Hunter Coombes; Edward C Meek; Mary Beth Dail; Howard W Chambers; Janice E Chambers
Journal:  Toxicol Lett       Date:  2014-08-02       Impact factor: 4.372

10.  A common haplotype within the PON1 promoter region is associated with sporadic ALS.

Authors:  John E Landers; Lijia Shi; Ting-Jan Cho; Jonathan D Glass; Christopher E Shaw; P Nigel Leigh; Frank Diekstra; Meraida Polak; Ildefonso Rodriguez-Leyva; Stephan Niemann; Bryan J Traynor; Diane McKenna-Yasek; Peter C Sapp; Ammar Al-Chalabi; Anne-Marie A Wills; Robert H Brown
Journal:  Amyotroph Lateral Scler       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.